Skip to search formSkip to main contentSkip to account menu

telenzepine

Known as: 4,9-dihydro-3-methyl-4-((4-methyl-1-piperazinyl)acetyl)-10H-thieno(3,4-b)(1,5)benzodiazepin-10-one 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

ParasympatholyticsPirenzepine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Nitric oxide‐dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine
The aim of the present study was to investigate whether muscarinic M1 receptor activation induces intestinal relaxation via nerve… 
1997
1997
Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy.
In six conscious dogs we compared the action of the M1-receptor antagonist telenzepine (20.25-81.0 nmol.kg-1.h-1), the… 
1996
1996
M1-muscarinic mechanisms regulate interdigestive cycling of motor and secretory activity in human upper gut
We determined the influence of M1-muscarinic pathways in modulating temporal cycling of motor and secretory activity in the… 
1995
1995
Comparison of Two Dose‐Response Techniques to Study the Pancreatic Secretory Response to Intraduodenal Tryptophan in the Absence and Presence of the M1 ‐Receptor Antagonist Telenzepine
To answer the questions if the type of continuous dose-response technique influences the pancreatic secretory response to… 
1993
1993
The muscarinic M1-receptor-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients.
In a double-blind, placebo-controlled, randomized, cross-over trial, we studied the effects of the muscarinic M1-receptor… 
1991
1991
Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
In conscious dogs with gastric and pancreatic fistulas, we compared the action of different doses of telenzepine (ranging from 9… 
1990
1990
[3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
163 patients with endoscopically proven benign gastric ulcers were randomly allocated to treatment with either telenzepine 3 mg… 
1989
1989
Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
The new M1-receptor antagonist telenzepine has been studied for its antisecretory effect in different in vitro and in vivo… 
1989
1989
Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells
Summary(1) In the lumen-perfused mouse stomach in vitro, potential sites of gastric antisecretory action of the muscarine M1… 
1988
1988
Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
In different rat models, the antisecretory and antiulcer effects of the M1-antimuscarinics telenzepine and pirenzepine, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)